title: Effect of L-threo-3,4-dihydroxyphenylserine on muscle sympathetic nerve activity in humans.
abstract: To clarify the effect of L-threo-3,4-dihydroxyphenylserine (L-threo-DOPS), a precursor of norepinephrine (NE), the effect of this drug on microneurographically recorded muscle sympathetic nerve activity (MSA) from the tibial nerve was analyzed in ten healthy male volunteers. A single dose of 600 mg of L-threo-DOPS was orally administered and the effect of this norepinephrine precursor on MSA at resting and at upright standing positions, as well as the MSA responsiveness to head-up tilting was examined by comparing the data obtained after administration of the drug with those obtained under control conditions. The plasma NE levels were determined in two subjects. The results were as follows: (1) resting MSA increased significantly 80 min after administration of L-threo-DOPS and was accompanied by an increase in plasma NE levels; (2) standing MSA when treated with the drug was not significantly different from values obtained under control conditions; and (3) MSA responsiveness to orthostasis was reduced after L-threo-DOPS. We conclude from the activation of MSA by L-threo-DOPS that this drug raised blood pressure not only through an increase in metabolized plasma NE levels, but also through the enhancement of MSA by activation of descending noradrenergic or adrenergic pathways proximal to the recording site of the sympathetic discharge.
authors.affiliation: Department of Autonomic and Behavioral Neurosciences, Nagoya University, Japan.
authors.forename: S
authors.initials: S
authors.lastname: Iwase
authors.forename: T
authors.initials: T
authors.lastname: Mano
authors.forename: M
authors.initials: M
authors.lastname: Kunimoto
authors.forename: M
authors.initials: M
authors.lastname: Saito
mesh_terms: D000328:Adult; D001794:Blood Pressure / Q000187:drug effects*; D015103:Droxidopa / Q000494:pharmacology*; D006339:Heart Rate / Q000187:drug effects; D006801:Humans; D007024:Hypotension, Orthostatic / Q000188:drug therapy; D008297:Male; D009132:Muscles / Q000294:innervation*; D009434:Neural Pathways / Q000187:drug effects*; D009638:Norepinephrine / Q000097:blood*; D013564:Sympathetic Nervous System / Q000187:drug effects*; D013977:Tibia / Q000033:anatomy & histology
chemical_list: D015103:Droxidopa; D009638:Norepinephrine